Skip to content

The efficacy of a CBT relapse prevention program for remitted anxiety disorder patients who discontinue antidepressant medication.

The efficacy of a CBT relapse prevention program for remitted anxiety disorder patients who discontinue antidepressant medication. - Intervention study anxiety disorder patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON37997
Enrollment
220
Registered
2010-03-03
Start date
2010-09-20
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anxiety disorders

Interventions

The intervention consists of AD discontinuation and CBT in a group format. Based on prior research, efficacy is assumed. The control intervention consists of AD discontinuation alone.

Sponsors

GGZ inGeest (Amsterdam)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Included are adults aged 18-65 years i) who use AD for panic disorder (with or without agoraphobia), social phobia or generalized anxiety disorder; ii) who are in remission; and iii) who want to discontinue AD.

Exclusion criteria

Exclusion criteria: Patients with a comorbid dementia, psychotic disorder, alcohol or drug dependence or who do not speak Dutch are excluded.

Design outcomes

Primary

MeasureTime frame
Primary outcome measure is relapse within a year.

Secondary

MeasureTime frame
Secondary outcome measures are i) time to relapse; ii) one-year course of anxiety symptoms; iii) quality of life; iv) patient satisfaction; v)predictors of relapse; vi) cost-effectivity; and vii) cost-utility.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)